/Companies

NZeno

New Zealand, NZ · 3 known investors

Find your way into NZeno

Sign up to see every warm intro you have to NZeno

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NZeno team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NZeno develops porcine (pig) cell-based therapeutics and xenotransplantation technologies, building on work in encapsulated cell therapies and breeding pigs certified as tissue sources for human transplantation. The company operates in the biotechnology and regenerative medicine field.

Founders & leadership

PTPaul Tan
Paul TanFounder Director & Chief Medical OfficerPaul Tan is Founder Director and Chief Medical Officer of NZeno, a biotechnology company developing porcine cell-based therapeutics and xenotransplantation technologies. He has over 20 years of experience in biotechnology and therapeutic development, including prior involvement in clinical human xenotransplantation work.
OGOlga Garkavenko
Olga GarkavenkoFounder Director & Chief Scientific OfficerOlga Garkavenko is Founder Director and Chief Scientific Officer of NZeno, a biotechnology company developing porcine cell-based therapeutics and xenotransplantation technologies. She holds three patents in cell biology and has expertise in cell and regenerative medicine research, regulatory compliance, and scientific communication across multiple languages.
BEBob Elliott
Bob ElliottFounder & Director (Retired 2020)
PL
Peter LaiChief Executive Officer

Board

HMHoward Moore
Howard MooreChairman of the Board of DirectorsDirector at Cure Kids Ventures

Investors · 3

Frequently asked questions

What does NZeno do?
NZeno develops porcine (pig) cell-based therapeutics and xenotransplantation technologies, building on work in encapsulated cell therapies and breeding pigs certified as tissue sources for human transplantation. The company operates in the biotechnology and regenerative medicine field.
Who founded NZeno?
NZeno was founded by Paul Tan, Olga Garkavenko, Bob Elliott.
Who are NZeno's investors?
NZeno's investors include Cure Kids Ventures, NZ Growth Capital Partners, Pacific Channel.
Where is NZeno headquartered?
NZeno is headquartered in New Zealand, NZ.